<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - CALP</title>
<description>International Business News - CALP</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Caliper Life Sciences wins $1.1M for EPA testing</title>
  <description>Caliper Life Sciences Inc. announced Tuesday that it has received a $1.1 million federal environmental order to continue its work developing new ways to identify potentially toxic chemical compounds.</description>
    <link>http://www.ibtimes.com/articles/20080819/caliper-life-sciences-wins-1-1m-for-epa-testing.htm</link> 
  <pubDate>Tue, 19 Aug 2008 13:59:41 EDT</pubDate>
  </item>


  <item>
  <title>Caliper maintains 2008 revenue guidance</title>
  <description>Caliper Life Sciences Inc., which makes software used for drug development, maintained its full-year 2008 guidance Wednesday, despite reporting a wider loss for the second quarter.</description>
    <link>http://www.ibtimes.com/articles/20080806/caliper-maintains-2008-revenue-guidance.htm</link> 
  <pubDate>Wed, 06 Aug 2008 17:49:20 EDT</pubDate>
  </item>


  <item>
  <title>Caliper loss widens in second quarter</title>
  <description>Caliper Life Sciences Inc. said Wednesday its second-quarter loss widened on lower licensing revenue from its drug-development software programs. For the period ended June 30, Caliper reported a net loss of $6.7 million, or 14 cents per share, compared with $6.3 million, or 13 cents per share, in the same period last year.</description>
    <link>http://www.ibtimes.com/articles/20080806/caliper-loss-widens-in-second-quarter.htm</link> 
  <pubDate>Wed, 06 Aug 2008 17:15:27 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Life-sciences companies</title>
  <description>Continued demand for drug research and development tools has likely translated into strong second-quarter profit for life-sciences companies, which begin reporting financial results next week.</description>
    <link>http://www.ibtimes.com/articles/20080715/sector-snap-life-sciences-companies.htm</link> 
  <pubDate>Tue, 15 Jul 2008 14:53:54 EDT</pubDate>
  </item>


  <item>
  <title>Russell 2000 adds 53 health care companies</title>
  <description>More than 50 companies in the health care sector were added to the Russell 2000 in this year&amp;#39;s reconstitution of the small stock index, while 30 companies in the sector were removed from the index.</description>
    <link>http://www.ibtimes.com/articles/20080630/russell-2000-adds-53-health-care-companies.htm</link> 
  <pubDate>Mon, 30 Jun 2008 14:16:09 EDT</pubDate>
  </item>


  <item>
  <title>Market Spotlight: Life Sciences</title>
  <description>Invitrogen Corp.&amp;#39;s recent $6.4 billion deal to buy Applied Biosystems Group has ramped up speculation about further consolidation in the life sciences sector, as companies vie for larger market share.</description>
    <link>http://www.ibtimes.com/articles/20080619/market-spotlight-life-sciences.htm</link> 
  <pubDate>Thu, 19 Jun 2008 13:47:55 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Invitrogen deal lifts life sciences</title>
  <description>Invitrogen Corp.&amp;#39;s planned $6.4 billion buyout of Applera&amp;#39;s Applied Biosystems Group shone a spotlight on the wider life sciences product industry Thursday, boosting investor interest and share prices.</description>
    <link>http://www.ibtimes.com/articles/20080612/sector-snap-invitrogen-deal-lifts-life-sciences.htm</link> 
  <pubDate>Thu, 12 Jun 2008 15:21:14 EDT</pubDate>
  </item>


</channel>
</rss>